Cansativa
Founded 2017 · 65 employees on LinkedIn · 5 known investors
Find your way into Cansativa
Cansativa is a wholesaler of medical cannabis, supplying pharmacies, industry, and public-sector partners with cannabis products across its brands (N!CE, AMICI, Peace Naturals, Lit). Based in Germany, it focuses on distribution of medical cannabis and international market expansion within Europe.
Also known as Cansativa GmbH · Cansativa Group
Investors · 5
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BFeb 2022
Casa Verde (lead), Alluti, Argonautic Ventures
Source ↗ - Undisclosed amountSeries AJun 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Cansativa, operating publicly as Cansativa Group, is a German wholesaler of medical cannabis. It positions itself as an established wholesaler and market-access provider, connecting suppliers and manufacturers of cannabis products with pharmacies, physicians and, indirectly, patients. Its offering combines a product catalogue sold through an online shop for pharmacies, informational and support services for prescribing physicians, and guidance for patients seeking access to therapy.
The company markets a portfolio of four brands: AMICI (positioned as premium medical cannabis), N!CE (value-oriented), Peace Naturals (described as Canadian-origin innovation) and Lit (high-potency, low-price). Alongside distribution, Cansativa publishes a regular "Cannabis Briefing" newsletter and briefing articles covering medical cannabis regulation, reimbursement policy, market developments, research evidence and industry events, including coverage of German statutory health insurance (GKV) reimbursement rules, the French and UK medical cannabis markets, Swiss pilot-project regulation, and trade fairs such as ICBC Berlin and Mary Jane Berlin.
Business model
Cansativa acts as an intermediary in the medical cannabis supply chain: it sources products from suppliers and manufacturers, to whom it offers market access, and distributes them to pharmacies via a wholesale online shop, while also serving industry and public-sector customers. Its brand portfolio spans price tiers, including own brands N!CE and AMICI as referenced by customers.
Latest developments
Through 2026 the company published briefings on the exclusion of cannabis flowers from German statutory health insurance reimbursement, effective 30 July 2026, and on the associated GKV cost-containment legislation, alongside commentary on regulatory developments in France, Switzerland and the United Kingdom.
▸Full profile — market position, technology, go-to-market, geography, risks & controversies
Market position
Describes itself as a pioneer and established wholesaler for medical cannabis pursuing global expansion; customer testimonials cited on its site reference the breadth of its product portfolio and its price-performance positioning in the German market.
Technology
Operates an online ordering shop for pharmacy customers.
Go-to-market
Direct wholesale to pharmacies through an online shop, supported by physician-facing support services, patient-facing information on access to therapy, a partner network, and content marketing via briefing articles and a newsletter on medical cannabis regulation and market trends.
Pharmacies as the primary purchasing channel, prescribing physicians, patients seeking access to medical cannabis therapy, suppliers and manufacturers seeking market access, and customers in industry and the public sector.
Geography
Germany-based, with a stated focus on international expansion; published briefings track medical cannabis markets in Germany, France, Switzerland and the United Kingdom.
Risks & controversies
The company's published briefings identify regulatory and reimbursement risk in its core German market, notably the exclusion of cannabis flowers from statutory health insurance reimbursement in force from 30 July 2026 and broader statutory health insurance cost savings affecting cannabis supply.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsCansativa reported that the exclusion of cannabis flowers from GKV reimbursement in Germany came into force on 30 July 2026, with consequences for affected patients.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 1
primary sources listed
- Cansativacansativa.de · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Cansativa do?
- German wholesaler of medical cannabis supplying pharmacies, doctors and patients through its own and partner brands.
- Who are Cansativa's investors?
- Cansativa's investors include Casa Verde Capital, Alluti GmbH, Argonautic Ventures, Greenfield.